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ABSTRACT 
Structural Determinants of Ionotropic Glutamate Receptor Function Revealed by Cryo-electron 
Microscopy   
Edward C. Twomey 
Fast excitatory neurotransmission is critical for learning and memory, and its 
dysregulation is linked to numerous neurological diseases. These include developmental diseases 
such as fragile X syndrome, psychiatric disorders like schizophrenia, and chronic 
neurodegenerative disorders such as Parkinson’s and Alzheimer’s diseases. Throughout the 
central nervous system, AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-
subtype ionotropic glutamate receptors (AMPARs) mediate the fastest excitatory 
neurotransmission. In response to the neurotransmitter glutamate, AMPARs open their ion 
channels and allow cation flux through the post-synaptic membrane. This initiates rapid 
depolarization and signaling in the post-synaptic neuron. Nearly all AMPARs exist as complexes 
with auxiliary subunits, which are regulatory proteins that modulate receptor assembly, 
trafficking, pharmacology and function. These auxiliary subunits determine brain region-specific 
AMPAR signaling, and aberrancies in complex formation or function lead to neuropathologies. 
Despite their importance for CNS signaling and implication in neurologic disorders, the 
structural bases underlying the function of AMPARs and AMPAR complexes remain 
ambiguous, representing a critical barrier to our understanding of excitatory neurotransmission.  
As a consequence, structure-based design of neuro-therapeutics is largely undeveloped: there is 
only a single FDA-approved drug targeting AMPARs. 
To address these problems, I wanted to dedicate my thesis work to study AMPAR 
synaptic complexes across an array of functional states and provide a new foundation for our 
structural understanding of AMPAR signaling. First, I designed a covalent-fusion construct 
approach to guarantee assembly and expression of AMPAR synaptic complexes in heterologous 
cells (HEK293). Then, I developed purification protocols allowing me to obtain chemically 
homogenous and pure complex protein. Since synaptic signaling is highly dynamic, complexes 
of AMPARs with auxiliary subunits are conformationally heterogeneous and are not amenable to 
X-ray crystallography.  
Cryo-electron microscopy (cryo-EM) enabled me to approach these complexes 
structurally, where I could collect data and parse out heterogeneity through image classification. 
With cryo-EM, I solved the structure of an AMPAR bound to the auxiliary subunit stargazin, 
which promotes AMPAR activation. This work provided the first structural information on how 
AMPARs form complexes with regulatory subunits. In a following study, I solved the structure 
of an AMPAR in complex with a functionally distinct auxiliary subunit, GSG1L. In contrast to 
stargazin, GSG1L promotes inactivation and desensitization of AMPARs, thus having a 
neuroprotective effect. To further characterize the function of these auxiliary subunits, I designed 
chimeras between stargazin and GSG1L and examined their function electrophysiologically. 
This experiment revealed that AMPAR auxiliary subunits have a modular design, where variable 
extracellular domain regions, supported by a conserved transmembrane α-helical bundle, 
distinctly regulate function of the core AMPAR. This study provided the first evidence of how 
brain region-specific expression patterns of similarly-structured auxiliary subunits may 
contribute to unique AMPAR functions.  
More recently, I’ve taken advantage of the modulatory effects of stargazin on AMPARs 
and I applied cryo-EM to an AMPAR-stargazin complex. This study determined how AMPARs 
are activated by the neurotransmitter glutamate, and revealed a novel mechanism by which 
glutamate binding induces opening of AMPAR ion channels. Our data show that two-fold 
symmetric kinking of ion channel helices allows cation flux into neurons, which triggers 
neurotransmission. Importantly, this study also provides insights into how mRNA editing and 
patient-derived disease mutations in the transmembrane (i.e., resulting in aberrantly firing of 
receptors during epilepsy) reshape AMPAR function and excitatory neurotransmission.  
Collectively, the findings from my thesis work provide a new paradigm for the 
molecular-level understanding of glutamatergic neurotransmission throughout the CNS. These 
studies lay the groundwork for new directions in precision-medicine design of therapeutics 
targeting brain region-specific AMPAR synaptic complexes in neurological diseases. 
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BACKGROUND AND INTRODUCTION 
 
Glutamate and ionotropic glutamate receptors  
Glutamate (Figure 1.1a) is the principle excitatory neurotransmitter in the central nervous 
system (CNS) and is critical for sensory and cognitive functions1,2. It dictates communication 
between neurons through synapses, electrochemical junctions between neuronal cells, where the 
action potentials approaching pre-synaptic terminals trigger the vesicular release of glutamate 
into the synaptic cleft. Glutamate then diffuses across the synaptic cleft to the post-synaptic 
terminal, where it binds to specialized membrane proteins, ionotropic glutamate receptors 
(iGluRs). Upon binding of the agonist glutamate, these ligand-gated ion channels allow cations 
to flow into the post-synaptic cell through their pores. This results in depolarization of the post-
synaptic membrane and initiates further propagation of the electrical signal (Figure 1.1b). The 
influx of sodium and calcium ions through iGluRs also induces downstream GTPases and 
kinases to influence transcription factors that strengthen iGluR signaling1-3. Generally, as iGluRs 
dictate excitatory neurotransmission throughout the CNS, dysregulation of these proteins results 
in a broad range of neuropathological conditions1,2,4-6, including abnormal mental development, 
psychiatric disorders, memory loss (Alzheimer’s disease), movement disorders (Parkinson’s), 
motor neuron disease as well as seizure generation and neuronal damage. While iGluRs are 
currently known to be vital for proper CNS function, it was not until the mid-1900s that 
glutamate came into focus as a signaling molecule in the CNS.  
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 Early biochemical research found glutamate to be at disproportionately high 
concentrations in the brain compared to other amino acids11-13, though it was first widely 
believed to be primarily involved in CNS metabolism14-16.  In the late 1950s, however, evidence 
began to show that glutamate is indeed a chemical neurotransmitter; glutamate injected directly 
into the brains of dogs and apes selectively induced clonic seizures18,19.  Additional studies, 
showing that glutamate from purified rabbit brain extract can induce muscle contraction in 
crustacean tissue and spreading depression when applied in rabbit brain tissue20, further 
supported the notion that the membrane-depolarizing action of glutamate governed electrical 
signaling in the CNS. Then, the most concrete evidence came when it was shown that 
extracellular administration of glutamate induces fast, excitatory currents in neuronal cells and 
an increase in action potential firing21,22.  
Figure 1.1. Glutamate and iGluR-mediated signaling. a, Structure of the amino acid and neurotransmitter 
glutamate. At physiological, neutral pH, the carboxyl group COOH is deprotonated and thus glutamate carries a 
negative charge. b, Cartoon illustration of a simplified synapse, reproduced from reference7 with publisher 
permission. iGluRs of various subfamilies decorate the post-synaptic cell. These include the α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic receptor (AMPAR), N-methyl-D-aspartate receptor (NMDAR) and kainate receptor 







While these studies began to mark the importance of glutamate for excitatory 
neurotransmission, the post-synaptic receptor proteins responding to glutamate, iGluRs, a new 
family of ligand-gated ion channels, were not cloned-out as the principle components responsible 
for the actions of glutamate in neurons until the 1990s23. Pharmacological development preceded 
cloning of the iGluRs and allowed three principle iGluR subfamilies to be identified24. This 
included the synthesis of the negatively charged amino acids α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic (AMPA), N-methyl-D-aspartate (NMDA) and kainate (KA), which seemed 
to induce specific depolarization patterns25-29. These potentials were also specifically inhibited by 
the antagonists D-α-aminoadipate30 and glutamtic acid diethyl ester31, which would either inhibit 
NMDA receptor (NMDAR) or non-NMDA-related currents, respectively32,33. Following, the 
discovery of highly-selective quinoxalinediones34-37, which are organic compounds with a 
bicyclic core, allowed for more selective inhibition of the non-NMDARs: AMPA receptors 
Figure 1.2. Three behaviors of glutamatergic signaling. A, Typical mixed excitatory post-synpatic potential, 
with a rise time of 3.5 ms and a falling phase of 200 ms. B, Example of a slow post-synaptic potential, with rise 
time of 22 ms and a falling phase of 200 ms. C, Fast post-synaptic potential with a rise time of 3.5 ms and 50 ms 
falling phase. All traces are averages of 16 potentials. Dotted lines indicate the resting potentials. Reproduced from 
reference10 under the Creative Commons Attribution License (CC-BY).  
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(AMPARs) or KA receptors (KARs), resulted in further delineation of iGluR subfamily 
contributions to post-synaptic depolarization. For example, AMPARs were found to be 
responsible for the initial, fast component of the post-synaptic density (PSD) depolarizing 
currents10,33,38. Experiments in Xenopus laevis embryos showed that post-synaptic potentials 
exhibited three behaviors10 (Figure 1.2). One was a potential with a fast rise time and slow 
falling phase (Figure 1.2A). The other two potentials, one with a slow, 22 ms rise time and 200 
ms falling phase (Figure 1.2B) and another one with a fast 3.5 ms rise time and 50 ms falling 
phase (Figure 1.2C), seemed to be individual components of a greater, sum potential. Adding the 
latter two potentials together would account for the post-synaptic potential observed in Figure 
1.2A. Following, the components were identified as NMDAR- (slow) and non-NMDAR-related 
(fast) using NMDAR-specific antagonists.  
These pharmacologic tools were instrumental in the identification of cloned iGluRs to 
discern subfamily-specific function. In 1984, a study where mRNA was isolated from human 
brain and injected into Xenopus laevis oocytes showed that glutamate and kainate could induce 
currents from the cells39. Expanding upon this work, a cDNA library from brain mRNA was 
produced and GluR1, the first AMPAR clone, was identified40. Following the initial 
identification of the GluR1 amino acid sequence, six other labs cloned and identified AMPAR 
subunits GluR2-4, which recapitulated the fast component of excitatory neurotransmission, 
characteristic of non-NMDARs41-46. These four subunits, comprising the AMPAR iGluR 
subfamily, share ~70% sequence homology. Since then, an incredible amount of iGluRs, 
including NMDARs and KARs, have been identified and cloned across species, which are 
discussed in-depth in several reviews1,23,47. The remainder of this thesis will focus on AMPARs 
and AMPAR signaling.  
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Architecture of AMPARs 
Before describing the functional landscape and features, it is helpful to discuss the 
structural topology of AMPARs. AMPARs and iGluRs in general share a common modular 
structural design (Figure 1.3)48,49. All iGluRs are assemblies of four similar or identical subunits 
(A through D) organized into a layered architecture. A large extracellular domain (ECD) 
Figure 1.3. Structural arrangement of AMPARs and iGluRs. a, Crystal structure of a homotetrameric AMPAR 
composed of GluA2 subunits in the closed, competitive antagonist ZK200775-bound state (PDB ID: 3KG2) viewed 
parallel to the membrane. Each of the four GluA2 subunits are colored differently: green (A), red (B), blue (C) and 
yellow (D). ZK200775 molecules are shown as a space-filling models. b, Single GluA2 subunit (A/C), rainbow-
colored from blue (N-terminus) to red (C-terminus). The LBD upper (D1) and lower (D2) lobes are indicated by 
gray, dashed contours. c, Representations of each iGluR domain layer (ATD, LBD, TMD) viewed extracellularly, 
parallel to the axis of the receptor overall two-fold rotational symmetry. The axes of local two-fold symmetry in the 
ATD and LBD dimers are labeled with grey ovals, overall two-fold symmetry with black ovals and local four-fold 
symmetry in the TMD with a black square. Gray, dashed contours encapsulate local dimer pairs in the ATD and 




comprises the amino terminal domain (ATD) layer that is necessary for assembly, trafficking and 
functional regulation of the receptor1,50 and the ligand binding domain (LBD)51 layer, which sits 
below the ATD and harbors binding sites for ligands that activate, modulate or antagonize the 
receptor. Below the ATD and LBD layers is the transmembrane domain (TMD)52 that forms a  
channel for cations to flow through the post-synaptic membrane. The cytoplasmic carboxy-
terminal domains (CTDs), which are involved in receptor localization and regulation53, have 
widely different sizes depending on the iGluR subunit. These likely form an intracellular fourth 
layer, but have so far evaded structural determination. 
Overall, the structures of iGluRs are two-fold symmetric, unique for tetrameric ion 
channels, where cross-subunit interactions and symmetry partners swap along the three-layered 
topology of the receptors54 (Figure 1.3c). In the ATD layer, local dimers between subunits A-B 
and C-D form on each side of the overall two-fold symmetry axis, with a cross-dimer interface 
between subunits B and D. In the LBD layer, the local dimer pairs are switched, A-D and B-C, 
and the cross-dimer interface is formed between subunits A and C. Each LDB is comprised of 
two polypeptide stretches, S1 and S2, which form a clamshell structure, with ligand binding 
occurring in the middle, between the LDB upper (D1) and lower (D2) lobes (Figure 1.3b). Upon 
agonist binding, the LBD clamshells close to induce channel opening in the TMD. The TMD, 
which has inverted orientation in the membrane compared to voltage-gated ion channels, is made 
up of three transmembrane helices (M1, M3 and M4) and a re-entrant intracellular loop M2 
between helices M1 and M3. The LBDs are tethered to the TMD through the flexible 
polypeptide linkers S1-M1, M3-S2 and S2-M4. These linkers communicate conformational 
changes in the LBD induced by ligand binding to the TMD. While the linker region is still two-
fold symmetric, the membrane-residing TMD is nearly four-fold symmetric. The M3 segments 
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line the extracellular portion of the ion channel pore, while M1 and M4 surround M3s and form 
the ion channel periphery. The re-entrant loop M2 includes an N-terminal helix, which forms 
extensive cross subunit interfaces, and an extended C-terminal region, which lines the 
intracellular portion of the ion channel pore and forms a selectivity filter.  
 Prior to solving the first full-length, high resolution structure of an iGluR, which was an 
AMPAR (assembled of GluA2 or GluR2 subunits) bound to the competitive antagonist ZK, X-
ray crystallography was used to elucidate the isolated structures of the LBD and ATD. Initial 
structural studies began to show the arangment of the iGluR ECD for the first time51. This work 
used sequence alignments between iGluR subunits and bacterial amino acid-binding proteins, of 
known structure, to establish the split polypeptides S1 and S2 as the functional unit of iGluR 
LBDs. Building on this, in 1998, the first structure of an iGluR LBD showed the two domain, D1 
and D2 (Figure 1.3b), arrangement around the ligand-binding pocket, in which S1 and S2 are 
arranged55. The structure of the ATD was finally solved in 2009, which also gave insights into 
receptor assembly and arrangement56. While the full-length crystal structure54, also in 2009, 
finally gave a complete view of how iGluRs are structurally and functionally arranged, early 
electron microscopy (EM) work57-60, though in the 20-40 Å resolution range, gave preliminary 
insights into the dimer-of-dimers arrangement of the receptor (Figure 1.3c).  
Gating in AMPARs 
The functional state of AMPARs is directly determined by the presence of glutamate in 
the LBD. I refer to gating in iGluRs, and in this specific case of AMPARs, as the general series 
of conformational changes in the receptor that occur upon ligand binding/unbinding to open or 
close the ion channel and affect the functional state of the receptor. A whole-cell patch-clamp 
current in response to a prolonged application of agonist glutamate (Figure 1.4a) illustrates three 
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Figure 1.4. Functional recording and kinetic model of AMPAR gating. a, Representative whole-cell patch-clamp 
current recorded at -60 mV membrane potential from a HEK-293 cell expressing GluA2 in response to a 0.5-s 
application of the agonist glutamate (black bar). Current components that are mainly determined by the three major 
gating processes, activation, desensitization and deactivation, are indicated by arrows. b, Simplified kinetic model of 
iGluR gating, with closed (C), pre-active (P), open (O) and desensitized (D) states. The agonist-bound states are 
indicated by “A” and the conducting state by “*”. Colors associated with each state C (blue), P (green), O (magenta) 
and D (orange). Reproduced from reference9 according to the ACS AuthorChoice License.  
 
major iGluR gating functions: activation, desensitization and deactivation. iGluR gating 
functions can also be described using kinetic models, which have become increasingly more 
complicated as the analysis of the kinetic components of channel current becomes more 
detailed61-65. However, the basic gating processes can be described by a simplified kinetic model 
that includes closed, pre-active, open and desensitized states (Figure 1.4b). In the absence of 
agonist (A), the receptors reside in a resting, non-conducting state C (closed). The concentration-
dependent process of agonist binding (C to CA transition) is immediately followed by 
conformational changes that place the receptor in a pre-active state (P), where it is ready to 
follow one of the two major functional routes: the receptor can either convert into a conducting 
(indicated by an asterisk ‘*’) state O (open) or adopt an active but non-conducting state D 
(desensitized). The PA to OA transition is much faster than PA to DA transition and defines the 
fast, sub-millisecond timescale rise in the inward current signifying the activation process 
(Figure 1.4a). Typically, however, the equilibrium between agonist-bound states is strongly 
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shifted towards DA and the majority of the receptors (95 to 99% for AMPARs) transition from 
OA to DA, underlying the current decline phase in the continuous presence of agonist and 
signifying the desensitization gating process (Figure 1.4a). Note, there is no direct transition 
between OA to DA61 and receptors have to visit PA in between. After agonist removal, receptors 
transition from all agonist-bound states (the majority are in DA) to the closed state C defining the 
recovery of the steady-state current to zero in the process of deactivation (Figure 1.4a). Typical 
AMPAR behavior is with cation influx and activation occurring under 1 ms, with desensitization 
occurring around 5 ms (Figure 1.4a). Deactivation, which is measured in response to a quick (2 
ms) application of glutamate, occurs under 2 ms.  
Importantly, besides states C54 and PA65,66, the two main functional states, OA and DA, are 
not characterized structurally, which is a critical barrier in our understanding of how these 
molecular machines work to govern neurotransmission. The focus of the work described in this 
thesis is how I approached this problem using structural biology.  
AMPAR Auxiliary Subunits 
 While studies on recombinant AMPARs in heterologous systems (i.e., Xenopus laevis or 
HEK293) gave critical insights into the function and gating of AMPARs, they were not able to 
exactly recapitulate the kinetics of synaptic AMPARs. The reason for this puzzling discrepancy 
was found with the discovery of auxiliary subunits, transmembrane proteins that form complexes 
with native AMPARs58 in neuronal cell membranes to modulate receptor kinetics, 
pharmacology, trafficking and localization67-71. In addition, recent proteomics studies72,73 
highlight the complexity of the AMPAR proteome, introducing the notion of AMPAR synaptic 
complexes, in which the receptors are decorated by an array of auxiliary subunits that 
differentially regulate AMPAR function in a brain region-specific manner17,74-76. Since these 
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Figure 1.5. Topologies of an AMPAR subunit and auxiliary subunit. Cartoons illustrating the topological 
features of AMPARs and TARPs. A single AMPAR GluA subunit (left) contains both the N-terminal domain 
(ATD) and LBD, and linker regions to connect the ECD to the TMD. The Q/R site is marked in magenta. TARPs 
(right) have four TM helices, linked together by intracellular and extracellular loops. The TARP C-terminal tail 
contains a PDZ (red; postsynaptic density-95/discs large/zona occludens-2) domain that is necessary for interaction 
with post-synaptic proteins. Figure reproduced from reference17 with publisher permission.  
 
subunits are critical for normal AMPAR function, disruption in auxiliary subunit-AMPAR 
interactions leads to aberrancies in synaptic plasticity and neurological disorders17,70,77. 
The first discovered (and most-studied) auxiliary subunit, transmembrane AMPAR 
regulatory protein (TARP) γ2, TARP-γ2 or stargazin (STZ), was originally found through a 
disrupted allele in the ataxic Stargazer mouse model78-80. STZ, which is enriched in synaptic 
membranes under normal conditions, was predicted to be a transmembrane protein with four TM 
helices based on topology prediction (Figure 1.5). Following studies showed the importance of 
STZ for trafficking and localization of AMPARs67,69,81-88, and in the mid-2000s, STZ and other 
members of the TARP family were shown to directly affect the gating kinetics and 
pharmacology of AMPARs71,81,82,88-93. These studies showed that STZ increases the amplitude of 
glutamate-evoked AMPAR-mediated currents, slows their deactivation and desensitization 
kinetics (by ~two and ~three-fold, respectively), and dramatically increases the efficacy of 
AMPAR partial agonists. Notably, STZ also increases the receptor open channel probability and 
similar effects on iGluR trafficking and gating? With an eye to
some of these broader questions, this review will summarize
key developments in our understanding of the TARP family
before moving on to a discussion of recent work on TARPs
and the ever-growing list of other AMPAR, NMDAR, and KAR
transmembrane auxiliary subunits. Interested readers are also
directed to several excellent reviews on the stargazer mouse
(Letts, 2005; Osten and Stern-Bach, 2006) and TARPmodulation
of AMPAR trafficking and gating (Nicoll et al., 2006; Sager et al.,
2009a; Payne, 2008; Coombs and Cull-Candy, 2009; Milstein
and Nicoll, 2008; Kato et al., 2010; Tomita, 2010; Dı´az, 2010b).
The iGluR Family and Its Regulation by Intracellular
Protein-Protein Interactions
Fast excitatory neurotransmission in the CNS is primarily medi-
ated by three classes of tetrameric iGluRs: AMPARs (GluA1–4),
NMDARs (GluN1, GluN2A–D, GluN3A–B), and KARs (GluK1–5),
alongwith a fourth, lesswell-characterized, class, the d receptors
(GluD1–2) (Collingridge et al., 2009). Sequence homology
between and within classes suggests that the general architec-
ture of iGluRs is modular and shares several common features
(Figure 1). Aside from sequence and structural differences,
iGluRs are distinguished by their differential pharmacology,
unique activation, deactivation and desensitization kinetics,
selective permeability, single-channel properties, and the unique
roles they play in different forms of both neuronal and glial
signaling (Wollmuth and Sobolevsky, 2004; Mayer, 2005; Tray-
nelis et al., 2010). To a large extent, iGluRs determine the shape
of synaptic currents at glutamatergic synapses. For AMPARs,
the kinetics of deactivation and desensitization, in addition to
other factors including subunit composition, RNA editing, and
alternative splicing, are key regulators of the amplitude and
kinetics of synaptic currents and determine their role in synaptic
integration, signaling, and plasticity (Jonas, 2000). Yet, rigorous
comparisons of AMPAR gating kinetics found recombinant
AMPARs (Mosbacher et al., 1994) to be faster than those of
native receptors (Colquhoun et al., 1992). In addition, the gating
properties analyzed at the single-channel level in heterologous
systems (Swanson et al., 1997) failed to match those recorded
from native receptors (Wyllie et al., 1993). A similar lack of
congruence existed between the kinetics of native (Castillo
et al., 1997) and heterologously expressed KARs (Swanson
and Heinemann, 1998). These findings suggested that additional
proteins might associate with native receptors and alter their
gating.
Over the past 20 years, tremendous progress has been made
toward identifying proteins that interact with iGluRs, thus unrav-
ling the olecular machinery that regulates the trafficking and
function of iGluRs. The picture that emerges is that iGluRs are
but one component of larger-scale, multimeric complexes.
This is of particular interest in the context of the postsynaptic
density (PSD) of excitatory synapses—a vast web of interacting
proteins that comprise large and dynamic supramolecular
assemblies (Scannevin and Huganir, 2000; Grant et al., 2005;
Yamauchi, 2002: Feng and Zhang, 2009). The C-terminal tails
(CTDs) of iGluRs have been a particular focus of attention in
this regard, because they exhibit a great deal of diversity in
length and sequence, and display numerous consensus sites
for phosphorylation and a variety of protein-protein interactions.
A myriad of cytosolic proteins have been identified that interact
with t e CTDs of iGluRs and regulate their membrane trafficking,
anchoring at synapses, and involvement in intracellular signaling
cascades. Depending on the particular class of iGluR, such
cytoplasmic proteins include postsynaptic density-95/discs
large/zona occludens-2 (PDZ) domain-containing proteins
(such as GRIP/ABP, PICK1, and a variety of membrane-associ-
ated guanylate kinase or MAGUK proteins), cytoskeleton-inter-
acting or scaffolding proteins (such as a-actinin, protein 4.1,
and spectrin), and the ATPase NSF (Song and Huganir, 2002;
Malinow andMalenka, 2002; Bredt andNicoll, 2003; Collingridge
et al., 2004; Kim and Sheng, 2004; Derkach et al., 2007; Lau and
Zukin, 2007; Elias and Nicoll, 2007). The CTDs of iGluRs are also
subject to phosphorylation by a variety of kinases such as
protein kinase C (PKC), protein kinase A (PKA), and calcium-
calmodulin kinase II (CaMKII), and by tyrosine kinases such as
src and fyn (Boehm and Malinow, 2005; Lee, 2006).
The stargazer Mutant Mouse and a New Family
of AMPAR Regulatory Proteins
The first bona fide transmembrane auxiliary subunit of an iGluR
wasdiscovered through thecharacterizationof stargazer, a spon-
taneousmutation in an inbredmouse line, originally distinguished
by its striking behavioral phenotype—dyskinesia, severe ataxia,
characteristic head-tossing, and frequent spike-wave
discharges (SWDs), reminiscent of absence epilepsy in humans
(Noebels et al., 1990). Genetic mapping revealed that the
stargazer mutation is attributable to a single recessive mutation
on mouse chromosome 15 (Letts et al., 1997). Subsequent
positional cloning showed that the locus of themutation encodes
























Figure 1. Major Structural Domains of AMPARs and TARPs
Illustration of the structural features of a closely apposed individual GluA
subunit (left) and a canonical TARP auxiliary subunit (right). The GluA subunit of
tetrameric AMPAR is composed of a large extracellular N-terminal domain
(NTD), the ligand-binding core, transmembrane domains, linker regions, and
s veral intracellular domains including the C-terminal tail (CTD). Agonists such
as glutamate (yellow) bind within the ligand-binding core to mediate channel
opening. The Q/R site (magenta) is the narrowest constriction of the AMPAR
pore and is an important determinant of its functional properties. The TARP
auxiliary subunit (right) consists of four transmembrane domains with a large
extracellular loop that is essential for TARP modulation of AMPAR gating. The
tip of the TARP CTD contains a PDZ bindingmotif (red), which is known to bind
to PDZ domain-containing proteins such as PSD-95, and which is essential for
the synaptic targeting of AMPARs.





occupancy of its maximum conducting state. While STZ positively modulates AMPAR 
activation, other auxiliary subunits favor desensitization. A prime example of this is the recently 
discovered subunit germline-specific gene 1-like (GSG1L)72,73, which only weakly affects 
deactivation and desensitization kinetics, but dramatically slows the recovery of AMPARs from 
desensitization.  
 While some of the AMPAR auxiliary subunits were characterized functionally at the start 
of my thesis work, there was no understanding of the structural determinants of how they might 
interact with AMPARs to regulate their function, besides an early EM study showing that STZ 
contributes to the AMPAR TM region58. In addition, noticing the unique modulatory effects of 
STZ and GSG1L, one favoring activation and the other desensitization, I surmised that using the 
properties of these subunits may be a viable approach for determining the structures of the 
missing OA and DA gating states. To approach these problems – elucidating the structures of 
auxiliary subunit complexes and the gating mechanism – I decided to use cryo-electron 
microscopy (cryo-EM).  
Cryo-electron microscopy 
 Cryo-EM is a revolutionary tool for obtaining the three-dimensional structures of 
biological specimens8,94-97. The specimens are suspended in a thin layer of amorphous ice and 
imaged in an electron microscope and kept at cryogenic temperatures, which are necessary for 
reduction of sample radiation damage. Electrons passing through the specimen are scattered by 
the sample suspended in the ice, and not the ice itself, which is amorphous.  The two-
dimensional (2D) images collected by the microscope’s camera are projections of the three-
dimensional (3D) specimen, and through single particle reconstruction (SPR) techniques the 
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structure of the 3D specimen can be reconstructed from 2D images. My thesis focuses on using 
cryo-EM to understand and uncover AMPAR structure.   
Sample preparation for cryo-EM 
Samples (purified protein, in the case of this thesis) are prepared for cryo-EM on grids 
(Figure 1.6). Grids are circular mesh, typically ~3 mm in diameter, and made of metal. They are 
broken up by grid bars, which make squares across the grid surface (Figure 1.6b). Copper grids 
with a carbon mesh support (squares) are widely used in experiments, though throughout the 
work describe here I used gold grids with gold mesh (Au/Au). Au/Au grids have unique 
properties, in that the applied sample spreads across the grid differently (i.e., some samples stick 
to carbon), and there is less damage done by electrons to the sample as gold is a better conductor 
than carbon and a more stable support material96,98,99. Within each square are holes, which are 
typically 1-2 µm in diameter and spaced 1-2 µm from each other (enlarged inset, Figure 1.6b). 
Holes create the perforations in the grid square mesh, in which the applied sample is suspended 
over (emboldened hole, Figure 1.6b).  
Prior to sample application, grids are plasma cleaned. This is typically performed under a 
mixture of hydrogen and oxygen for 20-30 seconds, which removes contaminants and renders 
the grid surface hydrophilic. This property is critical for spread of the sample across the grid 
surface; when needed, plasma treatment can also be altered to increase the hydrophobicity of the 
grid, depending on the sample96,100. After plasma treatment, the grid is ready for sample 
application. A crude illustration of grid preparation is illustrated in Figure 1.6a. Tweezers hold 
the plasma treated grid. Optimally, the grid is held as near to the outer edge as possible (Figure 
1.6b) to avoid damage to the grid mesh.  A small volume of sample (typically 3 µl) is applied to 
the grid, and filter paper is used to blot away excess buffer from the sample and create a thin 
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Figure 1.6. Cryo-EM sample preparation. a, The vitrification setup. Tweezers (gray) hold a grid (gold), where the 
sample is applied. Filter paper (not illustrated) is gently applied to the grid and used to blot excess buffer away. The 
sample is vitrified by plunging the grid via the tweezers into the liquid ethane, which is cooled in a vessel 
surrounded by liquid nitrogen. b, Layout of a cryo-EM grid. The grid is broken up into squares by grid bars (thick 
lines). A close-up view of a square (black outline) shows how the square is a mesh perforated by holes in the 
material. An example hole (black outline), rotated 90˚, shows how the sample, in this case a glutamate receptor, is 
randomly oriented in a layer of amorphous ice. Incident electrons arrive at the detector with the sample in the 
featureless ice (shown in blue) being the major factor altering the path of the electrons arriving at the detector or 
camera. The resulting micrograph (c) shows readily discernible features of the glutamate receptor particles randomly 
oriented in the imaged hole.  
 
layer of sample across the mesh, and thus over the holes. Optimizing the filter paper blotting 
time is critical for thin ice, which is needed for high-contrast images (Figure 1.7c; expanded 
upon below in “Electron microscopes and image formation”). However, ice that is too thin can 
damage the sample, and limit the randomness of particle distribution in the ice, which is critical 
for SPR (discussed in “Image processing for cryo-EM”).  
 After blotting, the sample is plunged into a well of liquid ethane (near -180 °C), which is 
surrounded by a larger pool of liquid nitrogen (-196 °C), thermally coupled to the inner well to 
keep the ethane cold (Figure 1.7a). The development of sample flash freezing leading to 
vitrification was critical for the development of cryo-EM101-104.  This procedure creates 
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amorphous, non-crystalline ice, so when the sample is imaged in the electron microscope (Figure 
1.7b,c), the particles in the sample are the major feature deflecting electrons, rather than a crystal 
lattice from crystalline ice (that would be formed if the freezing is slow). In addition, vitrified ice 
can withstand the vacuum of an electron microscope, and the quick freezing allows particles in 
the sample of interest to be frozen in random orientations (Figure 1.6b), which is critical for 
reconstructing the 3D density of the sample (see “Image processing for cryo-EM”). Vitrification 
also has the advantage of freezing sample in a hydrated state, which mimics a native-like 
environment. Importantly, the samples are directly stored liquid nitrogen after vitrification. 
During imaging (“Electron microscopes and image formation,” below) the sample is kept cold in 
the microscope via a cold stage, which is thermally coupled to liquid nitrogen in order to 
maintain the hydrated state of the sample103,105,106. Grid preparation is usually performed with the 
help of a robot and controlled chamber (i.e., the FEI Vitrobot), which allows for humidity and 
temperature control, as well as specific blot times to be used. The use of a robot and controlled 
chamber also allows for more reproducibility in grid preparation.  
Electron microscopes and image formation 
 Once prepared, the sample on the grid is imaged in an electron microscope (Figure 1.7). 
An electron microscope is much like a light microscope, though the light source is replaced by 
electrons and the lenses are magnetic rather than glass. Incident electrons are released into the 
high-vacuum microscope column from a field emission gun (FEG)107,108, which is a single 
tungsten crystal sharpened to a 10-25 nm point with a zirconium oxide coating at the tip8,109. The 
FEG is heated, which increases the thermal energy of electrons. When this energy exceeds the 
work function of the tungsten, the electrons are emitted from the sharpened tip and are 
accelerated by a potential gradient, typically 300 kV for high-resolution cryo-EM. The released 
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Figure 1.7. Schematic of an electron microscope. Adapted from reference8 with permission. 
electrons are coherent, having constant phase difference, and monochromatic (the same 
wavelength). The acceleration voltage of the electrons directly limits the achievable resolution of 
the experiment109. The relationship between electron wavelength and acceleration voltage is 
described by de Broglie’s equation, where smaller wavelength (and thus higher resolution) is 
inversely related to acceleration voltage.   
 In electron microscopy, the incident electrons are directed into a high-vacuum column, 
where electromagnetic lenses direct the path of the electrons. An aperture at the top of the 
microscope column blocks electrons scattered from the FEG at high angles. Below, condenser 
lenses convert the electrons, diverging from the FEG, into a parallel beam. These electrons pass 
through the specimen (on a grid kept on a copper rod that is thermally-coupled to liquid 
nitrogen), which sits in the magnetic field of the objective lens. The objective lens is one of the 
most important parts of the imaging system, as it handles the electrons immediately after 
interaction (scattering) with the specimen and provides the initial magnification (20-50x) of the 
resulting image8. The objective aperture, below the objective lens in the microscope column and 
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Figure 1.8. Elastic and inelastic electron scattering. Incident electrons can be deflected by the sample electron 
cloud without energy loss (elastic) or directly collide with electrons or the nucleus, resulting in energy loss of the 
electron (inelastic). Adapted from reference8 with permission.  
 
in the back focal plane of the objective lens, is used to prevent electrons scattered at high angles 
from contributing to the image and therefore improves image contrast. The image is further 
magnified (~1,000x) by projector lenses prior to being recorded by a camera at the bottom of the 
microscope column.  
 The image formed in the electron microscope, which is recorded by the detector, results 
from variations in the electron beam from transmission through the specimen97. Electrons can 
interact with the specimen elastically or inelastically (Figure 1.8). Elastically scattered electrons 
are deflected by atomic nuclei at a specific scattering angle, but do not experience energy loss. 
Inelastically scattered electrons are those that have interacted with atoms and have transferred 
energy to the sample. This includes interactions with the electron cloud, ionizing the specimen, 
secondary electron scattering and X-ray emission. Resulting from inelastic scattering is 
incoherence of the electron beam and introduction of noise into the image. However, with 
biological samples, which are primarily composed of light atoms (carbon, hydrogen, oxygen and 
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nitrogen), only a small proportion of the electron beam is inelastically scattered and electron 
interactions at the specimen level are mostly elastic. Because of this, there is little amplitude 
contrast, and the energy of the incident electron beam is overall equivalent to the energy of the 
electron beam transmitted through the sample. This raises the question of how exactly the 
resulting image is formed, since there needs to be variations in the intensity of the transmitted 
beam for there to be contrast in the recorded image. This bright field image is formed by 
alterations in the transmitted beam that are from phase shift, which causes interference between 
the electrons that are elastically scattered by the sample and also those that are not scattered and 
directly transmit through the specimen ice. The phases of incident electrons are shifted by elastic 
scattering events from deflections with electron clouds in the randomly distributed sample 
particles, which changes the phases of the electrons compared to the incident electron beam. 
Thus, the specimen is a weak phase object – it alters the incoming electron beam through 
changing its path, but does not alter the energy. The exit wave of electrons, with shifted phases, 
interferes with the non-scattered, transmitted electrons, resulting in phase contrast that is 
recorded by the imaging system of the microscope. Therefore, phase contrast is responsible for 
the majority of contrast in the image110.  
 To increase the phase contrast, the images are collected at negative defocus values above 
the image plane111. However, specimen images must be collected along a range of defocus values 
(i.e., -1.0 µm to -3.0 µm) due to image information in Fourier space being sinusoidal, where 
when the function crosses the x axis (which describes spatial frequency) information on the 
specimen is lost. By imaging the sample along a range of defoci, specimen information across 
spatial frequencies is also collected. However, high-resolution information about the specimen is 
lost when collecting at lower (i.e., -4.0 µm, compared to -2.0 µm) defoci.  While defocus is 
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necessary compensate for signal loss and increase image contrast, aberrations in the 
microscope’s lenses contribute to distortion of the image. In a perfect lens (Figure 1.9a), 
electrons that are parallel to the principle axis of the lens will converge at the focal point, F. 
However, electromagnetic lenses often have aberrations that contribute to a loss of beam 
coherence.   Spherical aberration is image distortion from the focus of the incident electrons 
being dependent on the distance from the optical axis (Figure 1.9b). Chromatic aberration, which 
arises from variation in the electron energies (i.e., voltage fluctuation, inelastic scattering), 
results in electrons of different wavelengths being focused closer or farther away from the image 
(Figure 1.9c). Astigmatism, where a lens is stronger in one direction than the perpendicular 
direction, results in a stretched image when electrons deviate from axial symmetry (Figure 1.9d).  
Figure 1.9. Ray diagrams showing aberrations in lenses: a, an example of a perfect lens, and examples of (b) 




Image processing for cryo-EM 
 Due to imperfections in the lenses, especially in the objective lens, the projection image 
of the specimen appears as a blurred image97. The point spread function (PSF) describes the 
relationship between the blurred image and the specimen. To understand the individual 
contributions of lens aberrations to the blurred image, a Fourier transform is applied to the PSF, 
which describes the contrast transfer function (CTF). The product of the Fourier transform of the 
image and the CTF describes changes in the phase contrast contributing to the image due to the 
lens aberrations112. Understanding the CTF is critical for the description of image defects, and 
thus critical for SPR113,114.  
After CTF correction, the images are 2D projections of the Coulomb potential of the 
specimen. To reconstruct the density of the 3D specimen from the 2D projection images 
contained in the micrographs, the images must be carefully processed. Briefly, this processing 
includes: correcting the CTF of each image115 (described above), particle selection and 
extraction, particle alignment, classification and 3D reconstruction. Micrographs are collected on 
direct electron detection (DED) cameras, which use complementary metal oxide semiconductor 
(CMOS)-based pixels to directly read out individual electron events at each pixel115-121. This 
results in an incredible detective quantum efficiency (DQE), which is a measure of the camera’s 
signal-to-noise ratio (SNR) at a given acceleration voltage, where there is very little noise 
contributed to the image122,123. High SNR is in part contributed to by the ability of DED cameras 
to collect dose-fractionated micrographs, where the overall micrograph is a composition of 
movie frames (i.e., an 8 s specimen exposure broken down into 40 frames of 200 ms each). 
Through aligning the frames to each other, electron-induced specimen movement is reduced, and 
the signal from individual particles in the micrograph is increased, improving the SNR124-126. 
20 
	
This also allows for computational compensation of the radiation damage, where the contribution 
of each movie frame to the final, aligned micrograph can be weighted based on the frame 
number and overall electron dose127-130. 
 To acquire individual particle images from the CTF-corrected micrographs, particle 
coordinates must be found in each micrograph. This can be performed manually, but is now 
usually done in an automated131-133 or semi-automated134-139 procedure to speed up processing 
and reduce user error or bias.  Typically, a small subset of particles is manually picked by a user, 
which serves as templates for automated particle picking from the whole set of micrographs and 
allows for distinction of particles from background noise or contamination. Based on the 
identified particle coordinates, the individual particle images are extracted or cropped out of each 
micrograph. After normalization, where the average pixel intensity outside of the particle region 
is subtracted from the particle image, the particle images are projections of the Coulomb 
potential of the specimen. The images can then be classified in 2D, rotationally and 
translationally, which is useful for judging data quality and an initial assessment of the 
assortment of particle projections.  
Projection matching is used to obtain a 3D reconstruction of the specimen140,141, where 
each particle image is compared with back projections of the 3D reference density and the other 
particle images to evenly cover the entire angular space around the reference density, and is then 
assigned a reference angle. Optimally, the random particle orientations in the specimen (see 
“Sample preparation for cryo-EM) should provide projection images covering the angular space. 
The projection theorem forms the basis for the reconstruction procedure97,142. This states that the 
Fourier transform of a particle image, which is a 2D projection of the 3D specimen object, is a 
central slice of the Fourier transform of the 3D object, aligned perpendicularly to the direction of 
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projection. Therefore, missing particle views in the micrographs results in incomplete sampling 
of the Fourier space around the object and a skewed, inaccurate 3D reconstruction.  
Importantly, image classification methods allow for heterogeneity in the specimen to be 
classified out97. This can be performed using supervised and unsupervised methods. Supervised 
classification can use multiple 3D references and then parse out differences in the particle images 
based on their relations to the provided references. These methods were established using the 
ribosome to parse out different conformational states, in addition to occupancy of ligands143,144. 
However, this can also lead to reference bias. Unsupervised image classification establishes 
different particle groupings based on similarities between particle images and their relation to a 
template generated from averaging clusters of particle images145,146. Recent improvements in 
classification use maximum-likelihood classification methods147-150, which rely on handling the 
class assignment of particles as a distribution of features (i.e. SNR, projection angle, 2D rotation 
and translation) with weights of particle images between class averages taken into consideration, 
rather than an all-or-none class assignment. Accuracy of the 2D translation and rotation 
alignments, and projection matching, is maximized in an iterative approach.  
In order to reduce the contribution of noise in the image to the reconstruction is to use 
Bayesian statistics. For example, the processing suite Regularized Likelihood Optimization 
(RELION), uses a maximum a posteriori (MAP) estimation with maximum-likelihood 
optimization to give more weight to the experimental information than the prior (i.e., reference 
density) information149. While this helps to reduce over-fitting of noise into the reconstruction 
(i.e., “Einstein from noise”151), user input is still required, such as choosing the number of classes 
to classify the data into, the number of iterations and the 3D reference density.  
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Briefly, 3D refinement in RELION begins with forming back projections (“projection 
matching”) of the 3D reference, filtered to a low resolution (i.e., 40 Å), and the likelihood of 
occupancy of each projection angle for the particle images is calculated. Then, broad, low-
resolution angular searches (i.e., 15°) are used to find regions where particle images are most 
likely to contribute to. After this initial projection angle assignment, finer angular searches are 
used to identify the correct projection angle of an image within the initially assigned region. In 
addition, the 2D images are aligned to other images in the same region to be properly rotated or 
translated for that projection image. This continues until there is a convergence in the accuracy 
of projection angle assignments. In RELION, this is automatically performed without user 
interference, and the dataset of particle images is broken up into two randomized halves and the 
number of iterations is determined without user interference until the data converges (i.e., there 
are no changes in the angular projections assigned to the input images). The output is a single 3D 
density. After each iteration, the dataset is broken up into random halves, and the Fourier shell 
correlation (FSC) is calculated between the two randomized subsets. The FSC provides 
information on the SNR as a function of the spatial frequency of the density, and measures 
correlation between the maps between the resolution shells of the two volumes. This is a less-
biased approach to estimating the resolution of the map152,153, which is estimated to be the point 
where the FSC is 0.143154. Projection matching is also used in classification, though the number 
of output classes (densities) is determined by the user, as well as the sampling angles and number 
of iterations. The particle images are randomly assigned to the provided number of classes, and 
images contributing to a class are aimed to be as similar as possible, while as different as 
possible compared to the other classes. Particle images are assigned classes based on similarities 
to the class averages, with more weight on the most-similar average.  
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CHAPTER 2. 
ELUCIDATION OF AMPA RECEPTOR-STARGAZIN COMPLEXES 
 This section is a paper published in Science155. The paper reveals the structural 
basis of AMPAR regulation by the auxiliary subunit stargazin. The structures of the 
complexes, solved via cryo-EM, show how stargazin can assemble around AMPARs at 
variable stoichiometries, the assembly interfaces and shed light on how extracellular 
contact surfaces, conserved throughout AMPARs and TARPs, may control fast excitatory 












































































































STRUCTURAL BASES OF DESENSITIZATION IN AMPA RECEPTOR 
COMPLEXES 
 This section is a paper published in Neuron156. The paper reveals the structural 
bases of desensitization in AMPARs and how different auxiliary subunits share common 








































































































CHANNEL OPENING AND GATING MECHANISM IN AMPA-SUBTYPE 
GLUTAMATE RECEPTORS 
 This section is a paper published in Nature157. The paper reveals the structural 
bases of channel activation and gating in AMPARs, as well as the first full-length 























































CONCLUSION AND OUTLOOK 
A couple of years ago the structural determinants of iGluR gating remained ambiguous. 
Now, the collection of AMPAR cryo-EM structures described in this thesis allow for structural 
visualization of the entire iGluR gating mechanism for the first time. This provides a foundation 
for understanding the major molecular processes that determine excitatory neurotransmission 
underlying how we think, learn, process and perceive. Briefly, the motions of the LBD local 
dimers and of the LBD tetramer (paired movements of the local dimers across the overall two-
fold symmetry axis) guide the TMD through the LBD-TMD linkers. When the linkers are 
relaxed the channel is non-conducting, with channel gates closed. Rupturing the D2-D2 interface 
upon agonist binding and activation puts tension on the LBD-TMD linkers and opens the channel 
for cation conductance. Desensitization is achieved through restoring the D2-D2 interface via 
rupturing the D1-D1 interfaces. This allows the LBD-TMD linkers to relax and the puts the 
TMD in a non-conducting state while the individual LBD clamshells are still in an active 
(maximally closed, agonist-bound) state. A pre-active state, where the individual LBDs begin to 
close, but the local LBD dimer interfaces are largely unchanged, as are the LBD-TMD linkers, 
appears to serve as a transition state between the resting, active and desensitized states.  
The principle gating change in AMPAR TMDs occurs in the B/D subunit M3 helices. 
There is a very pronounced kink at A618, a residue conserved across all eukaryotic iGluRs, 
which results in the opening of the upper ion channel gate by moving the elements contributing 
to the M3 bundle crossing away from the pore and overall two-fold symmetry axis of the 
receptor. Interestingly, this helix kinking disrupts access to the TMD collar binding cavities 
where the noncompetitive inhibitor and antiepileptic drug perampanel binds. This may explain 
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why administration of noncompetitive inhibitors to activated receptors is less efficacious in 
inhibition than when administering to resting state receptors, and will likely contribute to more 
informed design of noncompetitive inhibitors that target this region. Importantly, the collection 
of AMPAR structures in different gating states help to contextualize how mutations may disrupt 
normal AMPAR function and contribute to neurodegenerative states.  
In addition to uncovering the AMPAR gating mechanism, the structures outlined here 
provide the first glimpses into how AMPARs assemble with the auxiliary subunits that regulate 
their function in neurons. Both STZ and GSG1L are claudin-like, with a characteristic two-
domain architecture that includes a four α-helical bundle TMD and ECD marked by a ß-sheet 
with five ß strands. The structures show that while STZ and GSG1L have markedly different 
effects on AMPAR function, they show a common mode of assembly, and through unique 
moieties in the ECD (i.e., linkers between ß strands and TM helices) modulate activation or 
desensitization. I surmise that these findings may help to explain how similarly structured 
regulatory subunits, which have brain-region specific expression patterns, form uniquely 
functioning AMPAR synaptic complexes. 
 However, while this is a great beginning, many key questions remain unanswered: How 
conserved is the AMPAR gating mechanism in different iGluR subtypes? What are the structural 
determinants of multiple conductance states? What is the exact structural mechanism of iGluR 
assembly? What are structural mechanisms of small-molecule interactions with the gating 
machinery of iGluRs? What are the energetic determinants along the iGluR gating transitions? 
How do non-claudin like auxiliary subunits form complexes with AMPARs? How do different 
auxiliary subunits affect iGluR gating transitions? What are the structures of iGluR CTDs and 
how do these domains contribute to receptor function in neurons? I expect the coming years will 
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be an exciting time to address these and many other questions about iGluR structure and 
function, and that building upon the recent structures not only enhances our understanding of the 
molecular bases of excitatory neurotransmission but will also contribute to drug design and 
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